NDC 0480-5425
Sorafenib
Sorafenib
Sorafenib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals, Inc.. The primary component is Sorafenib Tosylate.
| Product ID | 0480-5425_213b5f06-be1f-4bc1-b09d-86c12f83d3b9 |
| NDC | 0480-5425 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sorafenib |
| Generic Name | Sorafenib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2023-01-03 |
| Marketing Category | ANDA / |
| Application Number | ANDA209567 |
| Labeler Name | Teva Pharmaceuticals, Inc. |
| Substance Name | SORAFENIB TOSYLATE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |